BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31832762)

  • 1. Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer.
    Sun RJ; Wang L; Li XT; Lu QY; Zhang XY; Guan Z; Sun YS
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):739-748. PubMed ID: 31832762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Akiyoshi T; Yamaguchi T; Hiratsuka M; Mukai T; Hiyoshi Y; Nagasaki T; Ueno M; Fukunaga Y; Konishi T
    Eur J Surg Oncol; 2021 Dec; 47(12):3157-3165. PubMed ID: 34284904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of extramural venous invasion and lateral lymph node size detected with magnetic resonance imaging is a reliable biomarker for lateral lymph node metastasis in patients with rectal cancer.
    Abe T; Yasui M; Imamura H; Matsuda C; Nishimura J; Haraguchi N; Nakai N; Wada H; Takahashi H; Omori T; Miyata H; Ohue M
    World J Surg Oncol; 2022 Jan; 20(1):5. PubMed ID: 34986842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Features in Pretreatment Metastatic Lateral Lymph Nodes in Locally Advanced Low Rectal Cancer Predict Distant Metastases.
    Kroon HM; Dudi-Venkata NN; Bedrikovetski S; Liu J; Haanappel A; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Sammour T
    Ann Surg Oncol; 2022 Feb; 29(2):1194-1203. PubMed ID: 34490529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
    Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
    J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
    Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
    Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management, treatment and prognostic significance of lateral lymph node metastases in rectal cancer-a regional cohort study.
    Agger E; Åkerlund V; Ekberg O; Jörgren F; Lydrup ML; Buchwald P
    Int J Colorectal Dis; 2021 Dec; 36(12):2707-2714. PubMed ID: 34487231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lateral lymph nodes without malignant characteristics on the prognosis of patients with rectal cancer.
    Zhang C; Cui M; Xing J; Yang H; Yao Z; Zhang N; Tan F; Liu M; Xu K; Su X
    Future Oncol; 2022 Oct; 18(31):3509-3518. PubMed ID: 36317561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
    Schaap DP; Boogerd LSF; Konishi T; Cunningham C; Ogura A; Garcia-Aguilar J; Beets GL; Suzuki C; Toda S; Lee IK; Sammour T; Uehara K; Lee P; Tuynman JB; van de Velde CJH; Rutten HJT; Kusters M;
    Br J Surg; 2021 Mar; 108(2):205-213. PubMed ID: 33711144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
    Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 18. Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method.
    Crimì F; Cabrelle G; Campi C; Schillaci A; Bao QR; Pepe A; Spolverato G; Pucciarelli S; Vernuccio F; Quaia E
    Eur Radiol; 2024 May; 34(5):3205-3214. PubMed ID: 37930408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lateral lymph node involvement presents another challenge in rectum cancer in the age of neoadjuvant chemoradiotherapy + total mesorectal excision: an evaluation of survival outcomes.
    Özdemir Ü; Gündoğdu E; Yakar M; Canaz F; Ulaş M; Özer İ
    Langenbecks Arch Surg; 2023 Sep; 408(1):356. PubMed ID: 37702958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
    Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
    Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.